Search Results

There are 12578 results for: content related to: An observational study of the effectiveness and safety of intramuscular olanzapine in the treatment of acute agitation in patients with bipolar mania or schizophrenia/schizoaffective disorder

  1. You have free access to this content
    Olanzapine: Preclinical and Clinical Profiles of a Novel Antipsychotic Agent

    CNS Drug Reviews

    Volume 6, Issue 4, December 2000, Pages: 303–363, Gary D. Tollefson and Cindy C. Taylor

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3458.2000.tb00155.x

  2. Olanzapine in Treatment for Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient, Second Edition

    Mauricio Tohen, Giedra Campbell, Juan-Carlos Gómez, Pages: 79–107, 2011

    Published Online : 13 APR 2011, DOI: 10.1002/9780470975114.ch6

  3. Pharmacokinetics and tissue distribution of olanzapine in rats

    Biopharmaceutics & Drug Disposition

    Volume 20, Issue 8, November 1999, Pages: 369–377, Manickam Aravagiri, Yaroslav Teper and Stephen R. Marder

    Article first published online : 22 JUN 2000, DOI: 10.1002/1099-081X(199911)20:8<369::AID-BDD200>3.0.CO;2-6

  4. Olanzapine in Treatment for Bipolar Disorder

    Bipolar Psychopharmacotherapy: Caring for the Patient

    Mauricio Tohen, Giedra Campbell, Daniel Lin, Pages: 85–103, 2006

    Published Online : 31 MAY 2006, DOI: 10.1002/0470017953.ch6

  5. You have free access to this content
    Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring

    Journal of Pharmacy and Pharmacology

    Volume 66, Issue 6, June 2014, Pages: 747–759, Thomas Vella and Janet Mifsud

    Article first published online : 7 JAN 2014, DOI: 10.1111/jphp.12209

  6. You have free access to this content
    Hormonal and Metabolic Effects of Olanzapine and Clozapine Related to Body Weight in Rodents


    Volume 14, Issue 1, January 2006, Pages: 36–51, Vance L. Albaugh, Cathy R. Henry, Nicholas T. Bello, Andras Hajnal, Susan L. Lynch, Beth Halle and Christopher J. Lynch

    Article first published online : 6 SEP 2012, DOI: 10.1038/oby.2006.6

  7. You have full text access to this OnlineOpen article
    Antipsychotics inhibit glucose transport: Determination of olanzapine binding site inStaphylococcus epidermidis glucose/H+ symporter

    FEBS Open Bio

    Volume 5, Issue 1, January 01, 2015, Pages: 335–340, Petr Babkin, Alayna M. George Thompson, Cristina V. Iancu, D. Eric Walters and Jun-yong Choe

    Article first published online : 15 APR 2015, DOI: 10.1016/j.fob.2015.04.006

  8. Olanzapine alone or in combination for acute mania

    Intervention Review

    The Cochrane Library

    Jennifer M Rendell, Harm J Gijsman, Paul K Keck, Guy Goodwin and John Geddes

    Published Online : 20 JAN 2003, DOI: 10.1002/14651858.CD004040

  9. Olanzapine versus other atypical antipsychotics for schizophrenia

    Intervention Review

    The Cochrane Library

    Katja Komossa, Christine Rummel-Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling and Stefan Leucht

    Published Online : 17 MAR 2010, DOI: 10.1002/14651858.CD006654.pub2

  10. Olanzapine in long-term treatment for bipolar disorder

    Intervention Review

    The Cochrane Library

    Andrea Cipriani, Jennifer M Rendell and John Geddes

    Published Online : 21 JAN 2009, DOI: 10.1002/14651858.CD004367.pub2

  11. Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5′-monophosphate-activated protein kinase

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 12, December 2013, Pages: 1128–1135, M. Ikegami, H. Ikeda, T. Ohashi, M. Ohsawa, Y. Ishikawa, M. Kai, A. Kamei and J. Kamei

    Article first published online : 11 JUL 2013, DOI: 10.1111/dom.12148

  12. You have free access to this content
    Safety and efficacy of olanzapine in the long-term treatment of Japanese patients with bipolar I disorder, depression: An integrated analysis

    Psychiatry and Clinical Neurosciences

    Volume 68, Issue 7, July 2014, Pages: 498–505, Hideaki Katagiri, Mauricio Tohen, David P. McDonnell, Shinji Fujikoshi, Michael Case, Shigenobu Kanba, Michihiro Takahashi and Juan-Carlos Gomez

    Article first published online : 4 MAR 2014, DOI: 10.1111/pcn.12156

  13. Lack of Pharmacokinetic Interaction Between Lamotrigine and Olanzapine in Healthy Volunteers

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 5, May 2006, Pages: 627–633, Dr. Michael W. Jann, Dr. Yuen Yi Hon, Dr. Shahab A. Shamsi, Dr. Jack Zheng, Dr. Eric A. Awad and Dr. Vicky Spratlin

    Article first published online : 6 JAN 2012, DOI: 10.1592/phco.26.5.627

  14. Plasma concentrations of high-dose olanzapine in a double-blind crossover study

    Human Psychopharmacology: Clinical and Experimental

    Volume 21, Issue 6, August 2006, Pages: 393–398, Deanna L. Kelly, Charles M. Richardson, Yang Yu and Robert R. Conley

    Article first published online : 19 JUL 2006, DOI: 10.1002/hup.781

  15. Olanzapine Transfer By Human Placenta

    Clinical and Experimental Pharmacology and Physiology

    Volume 26, Issue 9, September 1999, Pages: 691–697, S Schenker, Y Yang, E Mattiuz, D Tatum and M Lee

    Article first published online : 24 DEC 2001, DOI: 10.1046/j.1440-1681.1999.03111.x

  16. You have free access to this content
    The effect of ethinylestradiol-containing contraceptives on the serum concentration of olanzapine and N-desmethyl olanzapine

    British Journal of Clinical Pharmacology

    Volume 71, Issue 4, April 2011, Pages: 611–615, Tore Haslemo, Helge Refsum and Espen Molden

    Article first published online : 11 MAR 2011, DOI: 10.1111/j.1365-2125.2010.03880.x

  17. Olanzapine for schizophrenia

    Intervention Review

    The Cochrane Library

    Lorna Duggan, Mark Fenton, John Rathbone, Roland Dardennes, Ahmed El-Dosoky and Saroja Indran

    Published Online : 20 APR 2005, DOI: 10.1002/14651858.CD001359.pub2

  18. UGT1A4*3 Encodes Significantly Increased Glucuronidation of Olanzapine in Patients on Maintenance Treatment and in Recombinant Systems

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 2, August 2012, Pages: 221–227, T Haslemo, I Loryan, N Ueda, B Mannheimer, L Bertilsson, M Ingelman-Sundberg, E Molden and E Eliasson

    Article first published online : 20 JUN 2012, DOI: 10.1038/clpt.2012.46

  19. Characterization of olanzapine (LY170053) in human liver slices by liquid chromatography/tandem mass spectrometry

    Journal of Mass Spectrometry

    Volume 33, Issue 12, December 1998, Pages: 1237–1245, A. T. Murphy, B. G. Lake, J. R. Bernstein, R. B. Franklin and T. A. Gillespie

    Article first published online : 5 JAN 1999, DOI: 10.1002/(SICI)1096-9888(199812)33:12<1237::AID-JMS742>3.0.CO;2-F

  20. Dose-Dependent Alternations in the Pharmacokinetics of Olanzapine During Coadministration of Fluvoxamine in Patients With Schizophrenia

    The Journal of Clinical Pharmacology

    Volume 44, Issue 12, December 2004, Pages: 1385–1390, Dr Chih-Chiang Chiu, Dr Hsien-Yuan Lane, Dr Ming-Chyi Huang, Dr Hui-Ching Liu, Dr Michael W. Jann, Dr Yuen-Yi Hon, Dr Wen-Ho Chang and Dr Mong-Liang Lu

    Article first published online : 8 MAR 2013, DOI: 10.1177/0091270004270291